“…Ch/HAp nanocomposite coatings were biocompatible, in particular the Ch/10 wt.% HAp composition. [130] Ch, chitosan; HAp, hydroxyapatite; nHAp, nano hydroxyapatite; Ag, silver; β-GP, beta-glycerophosphate; ormoHAp, organically modified hydroxyapatite ZnO, zinc oxide; CaO, calcium oxide; NaOH, sodium hydroxide; SEM, scanning electron microscopy; TEM, transmission electron microscope; TGA, thermogravimetric analysis; XRD, X-ray diffraction; XPS, X-ray photoelectron spectroscopy; FTIR, Fourier transformed infrared spectroscopy; EDS, energy dispersive spectroscopy; AFM, atomic force microscope; DSC, differential scanning calorimetry; NPs, nanoparticles; Ti, titanium; BMD, bone mineral density; BET, Brunauer, Emmett, and Telleru method; µCT, micro computed tomography; CCHCs, chitosan/carbonated hydroxyapatite composite coatings; CCCs, calcium carbonate coatings; CHACs, carbonated hydroxyapatite coatings; NSN, net-shape-nonwoven; 3D, tridimensional; LDH, lactate dehydrogenase; MC3T3-E1, mouse Joint replacement demands a structure with high mechanical properties, which is not the case of any of the described forms of chitosan-HAp composite. For the purpose of preventing PJI, a chitosan-HAp composite in the form of a coating or paste to cover the metallic implant would be the most appropriate.…”